Abstract:Abstract BACKGROUND Diffuse midline glioma (DMG) is a fatal childhood brain cancer with a survival rate of less than one year from diagnosis. Pharmacological approaches and immunotherapy have failed to make a clinical impact. Incomplete understanding of the tumor microenvironment (TME) and tumor associated antigens have contributed to the observed poor prognosis. Therefore, mapping TME is urgently needed. METHODS Whole brains were collected at autopsy from 80 pediatric subjects, including patients diagnosed with DMG (n=50), GBM (n=9), non-malignant controls (n=10), ependymoma (n=5), ATRT (n=2). Up to four brain anatomical sites were selected: primary tumor, metastatic and adjacent healthy control sites, and processed for staining with hematoxylin and eosin (H&E). After reviewing the tumor and healthy regions, three punch cores were obtained resulting in a total of 918 core punches and two TMA blocks. Multiplexed immunofluorescence (MxIF) technology was used to probe 43 biomarkers on a single TMA slide, focusing on immune cell types and activation thereof. Clinical data including genomics alterations were obtained from each patient for downstream analyses. RESULTS Highest expressed immune markers across all patients were CD8 and CD3 (T-cells), CD68, Iba1 and CD163 (microglia). In DMGs, T-cells were mostly detected and increased in ONC201 and immunotherapy treated patients compared to only immunotherapy treated patients. Analysis of Iba1 confirmed a higher difference in activation in primary tumor compared to metastatic and adjacent healthy tissue, whereas in contrast, CD68 was significantly increased in metastatic sites. Patient plasma and RNA transcriptome analysis confirmed biomarkers and immune related pathways. Further, immune competent murine models were used to validate immune cell infiltration. AI deep learning technology modeling is ongoing now to, in future, be able to predict cell type composition and neighborhoods mapping. CONCLUSION We posit that this comprehensive data and characterization of the DMG TME will help to identify biology-informed targeted treatments.

PDTM-03. CHICKEN EMBRYO CHORIOALLANTOIC MEMBRANE (CAM) ASSAY AS A XENOGRAFT MODEL FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS

Chorioallantoic Membrane (CAM) Assay to Study Treatment Effects in Diffuse Intrinsic Pontine Glioma.

The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors

Feasibility of Probe Washing after Stereotactic Needle Biopsy As a Novel Technique for Developing Cell Lines and Xenografts of H3 K27-altered Diffuse Midline Gliomas.

Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas

DIPG-16. ACUTE VERSUS PROLONGED CONVECTION-ENHANCED DELIVERY OF ALISERTIB INTO H3 K27M-MUTANT MODELS OF DIFFUSE MIDLINE GLIOMA

The chick embryo chorioallantoic membrane as an experimental model to study in vivo angiogenesis in glioblastoma multiforme

Patient-derived DIPG Cells Preserve Stem-Like Characteristics and Generate Orthotopic Tumors.

Chick Embryo Chorioallantoic Membrane as a Platform for Assessing the In Vivo Efficacy of Chimeric Antigen Receptor T-cell Therapy in Solid Tumors

The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation

Establishment of patient-derived xenografts of retinoblastoma and choroidal melanoma on the avian chorioallantoic membrane

DIPG-21. EVALUATING THERAPEUTIC VULNERABILITIES IN DIPG USING AURORA KINASE INHIBITOR AS A NOVEL THERAPY

DIPG-14. EVALUATING THERAPEUTIC VULNERABILITIES IN DIPG TUMORS USING HIGH-THROUGHPUT SCREENING

Biomarker-Based PET Imaging of Diffuse Intrinsic Pontine Glioma in Mouse Models

DIPG-32. PRECLINICAL TESTING OF THE EFFICACY AND SAFETY OF CRISPR/CAS9 GENE EDITED CAR-T CELL THERAPY FOR DIFFUSE MIDLINE GLIOMA (DMG)

Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies

DIPG-66. MULTIPLEXED IMMUNOFLUORESCENCE MAPPING AND AI MODEL PREDICTION OF TUMOR MICROENVIRONMENT IN DIFFUSE MIDLINE GLIOMAS

DIPG-68. ONCOGENIC MECHANISMS OF H3.3 K27M IN A SPONTANEOUS DIPG MOUSE MODEL

Use of Chicken Embryos as an Angiogenesis Model for Central Nervous System Malignant Tumor Research

Tmod-36. Nanoglios: A Miniaturized Patient Avatar Enabling Rapid And High-Throughput Phenotypic Screening For Gliomas

Xenotransplantation of Pediatric Low Grade Gliomas Confirms the Enrichment of BRAF V600E Mutation and Preservation of CDKN2A Deletion in a Novel Orthotopic Xenograft Mouse Model of Progressive Pleomorphic Xanthoastrocytoma